• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TGF-β1 信号诱导的 VEGF-C 在胃癌中增强肿瘤诱导的淋巴管生成。

VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.

机构信息

Department of Surgery, Hallym University Medical Center, Hwasung, Korea.

Department of Medicine, Yonsei University Graduate School, Seoul, Korea.

出版信息

BMC Cancer. 2019 Aug 13;19(1):799. doi: 10.1186/s12885-019-5972-y.

DOI:10.1186/s12885-019-5972-y
PMID:31409309
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6692962/
Abstract

BACKGROUND

The role of TGF-β1 in lymph node metastasis and lymphangiogenesis, one of the most important steps of gastric cancer dissemination, is largely unknown. The goal of this study was to investigate the role of TGF-β1 signaling and its molecular mechanisms involved in lymphangiogenesis of gastric cancer.

METHODS

Two gastric cell line models, MKN45 and KATOIII, were selected for this study. The protein expression of TGF-β1 pathway molecules and VEGF-C were examined with western blot, or ELISA according to TGF-β1 treatment. To explore whether Smad3 binds to the specific DNA sequences in the VEGFC promoter, we performed an electrophoretic mobility shift assay. Lymphatic tube forming assay and gastric cancer xenograft mouse models were also used to elucidate the effect of TGF-β1 on lymphangiogenesis.

RESULTS

TGF-β1 induced the activation of Smad2/3 and Smad pathway-modulated VEGF-C expression in gastric cancer cell line models. Phosphorylated and activated Smad3 in the nucleus bound to the promoter of VEGFC in KATO III cells. Of note, in MKN45 cells, the Smad-independent AKT pathway was also activated in response to TGF-β1 and induced VEGF-C expression. Inhibition of TGF-β1 signaling down-regulated the expression of VEGF-C. We also confirmed, through tube forming assay and tumor xenograft mouse model, that TGF-β1 increased lymphatic formation, while TGF-β1 inhibition blocked lymphangiogenesis.

CONCLUSION

Smad-dependent and -independent TGF-β1 pathways induce VEGF-C, which make lymphangiogenesis around tumor. These findings suggest that TGF-β might be a potential therapeutic target for preventing gastric cancer progression and dissemination.

摘要

背景

TGF-β1 在淋巴结转移和淋巴管生成中的作用——胃癌扩散最重要的步骤之一,很大程度上仍不清楚。本研究旨在探讨 TGF-β1 信号通路及其在胃癌淋巴管生成中涉及的分子机制。

方法

选择两种胃细胞系模型 MKN45 和 KATOIII 进行本研究。用 Western blot 或 ELISA 根据 TGF-β1 处理检测 TGF-β1 通路分子和 VEGF-C 的蛋白表达。为了探究 Smad3 是否与 VEGFC 启动子中的特定 DNA 序列结合,我们进行了电泳迁移率变动分析。淋巴管生成分析和胃癌异种移植小鼠模型也用于阐明 TGF-β1 对淋巴管生成的影响。

结果

TGF-β1 诱导胃癌细胞系模型中 Smad2/3 的激活和 Smad 通路调节的 VEGF-C 表达。磷酸化和激活的核内 Smad3 与 KATO III 细胞中 VEGFC 的启动子结合。值得注意的是,在 MKN45 细胞中,TGF-β1 还激活了 Smad 非依赖性 AKT 通路,并诱导 VEGF-C 表达。抑制 TGF-β1 信号通路下调了 VEGF-C 的表达。我们还通过管形成分析和肿瘤异种移植小鼠模型证实,TGF-β1 增加了淋巴管形成,而 TGF-β1 抑制则阻断了淋巴管生成。

结论

Smad 依赖性和非依赖性 TGF-β1 通路诱导 VEGF-C,从而促进肿瘤周围的淋巴管生成。这些发现表明 TGF-β 可能是预防胃癌进展和扩散的潜在治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/e06caac720fa/12885_2019_5972_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/c98589fea2a7/12885_2019_5972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/55925e924768/12885_2019_5972_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/9a19f50b1282/12885_2019_5972_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/f7bbc248c336/12885_2019_5972_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/17421a7fa16c/12885_2019_5972_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/6de77bb7e8cc/12885_2019_5972_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/e06caac720fa/12885_2019_5972_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/c98589fea2a7/12885_2019_5972_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/55925e924768/12885_2019_5972_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/9a19f50b1282/12885_2019_5972_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/f7bbc248c336/12885_2019_5972_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/17421a7fa16c/12885_2019_5972_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/6de77bb7e8cc/12885_2019_5972_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/530b/6692962/e06caac720fa/12885_2019_5972_Fig7_HTML.jpg

相似文献

1
VEGF-C induced by TGF- β1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.TGF-β1 信号诱导的 VEGF-C 在胃癌中增强肿瘤诱导的淋巴管生成。
BMC Cancer. 2019 Aug 13;19(1):799. doi: 10.1186/s12885-019-5972-y.
2
MicroRNA-431-5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF-β1/SMAD2/3 signaling via ZEB1 in gastric cancer.microRNA-431-5p 通过影响 ZEB1 抑制 TGF-β1/SMAD2/3 信号通路抑制胃癌血管生成、淋巴管生成和淋巴结转移。
Mol Carcinog. 2024 Jul;63(7):1378-1391. doi: 10.1002/mc.23731. Epub 2024 Apr 24.
3
Lymphangiogenesis in gastric cancer regulated through Akt/mTOR-VEGF-C/VEGF-D axis.胃癌中的淋巴管生成通过Akt/mTOR-VEGF-C/VEGF-D轴调控。
BMC Cancer. 2015 Mar 7;15:103. doi: 10.1186/s12885-015-1109-0.
4
Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.胰岛素样生长因子-I 受体阻断减少肿瘤血管生成,并增强贝伐单抗对人胃癌细胞株 MKN45 的作用。
Cancer. 2011 Jul 15;117(14):3135-47. doi: 10.1002/cncr.25893. Epub 2011 Jan 24.
5
Opposite functions of HIF-α isoforms in VEGF induction by TGF-β1 under non-hypoxic conditions.非低氧条件下 TGF-β1 诱导的 VEGF 表达中 HIF-α 异构体的相反功能。
Oncogene. 2011 Mar 10;30(10):1213-28. doi: 10.1038/onc.2010.498. Epub 2010 Nov 8.
6
Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.VEGF-C 和 Smad4 在结肠癌淋巴管生成、淋巴转移和预后中的作用。
J Gastrointest Surg. 2011 Nov;15(11):2001-10. doi: 10.1007/s11605-011-1627-2. Epub 2011 Jul 23.
7
Kallistatin inhibits lymphangiogenesis and lymphatic metastasis of gastric cancer by downregulating VEGF-C expression and secretion.卡利他汀通过下调 VEGF-C 的表达和分泌抑制胃癌淋巴管生成和淋巴转移。
Gastric Cancer. 2018 Jul;21(4):617-631. doi: 10.1007/s10120-017-0787-5. Epub 2017 Dec 14.
8
MicroRNA MiR-130a-3p promotes gastric cancer by targeting Glucosaminyl N-acetyl transferase 4 (GCNT4) to regulate the TGF-β1/SMAD3 pathway.微小 RNA miR-130a-3p 通过靶向糖基化 N-乙酰转移酶 4(GCNT4)调控 TGF-β1/SMAD3 通路促进胃癌。
Bioengineered. 2021 Dec;12(2):11634-11647. doi: 10.1080/21655979.2021.1995099.
9
SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.SIX1 通过协调 TGFβ 信号增加 VEGF-C 的表达促进肿瘤淋巴管生成。
Cancer Res. 2014 Oct 1;74(19):5597-607. doi: 10.1158/0008-5472.CAN-13-3598. Epub 2014 Aug 20.
10
OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.氧化低密度脂蛋白通过上调 VEGF-C 的表达和分泌促进胃癌淋巴管生成和淋巴转移。
Int J Oncol. 2019 Feb;54(2):572-584. doi: 10.3892/ijo.2018.4648. Epub 2018 Nov 26.

引用本文的文献

1
SMAD3 orchestrates RNF167 and STAMBPL1-mediated Sestrin2 ubiquitination to drive gastric cancer progression.SMAD3 协调 RNF167 和 STAMBPL1 介导的 Sestrin2 泛素化以驱动胃癌进展。
Cell Div. 2025 Aug 1;20(1):20. doi: 10.1186/s13008-025-00163-z.
2
Liver Metastasis in Cancer: Molecular Mechanisms and Management.癌症中的肝转移:分子机制与治疗
MedComm (2020). 2025 Feb 27;6(3):e70119. doi: 10.1002/mco2.70119. eCollection 2025 Mar.
3
Difference between sentinel and non-sentinel lymph nodes in the distribution of dendritic cells and macrophages: An immunohistochemical and morphometric study using gastric regional nodes obtained in sentinel node navigation surgery for early gastric cancer.

本文引用的文献

1
Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade.Galunisertib,一种 TGFβRI 小分子抑制剂,通过靶向 TGFβ 通路,促进抗肿瘤免疫,从而导致持久、完全的反应,无论是作为单药治疗还是与检查点阻断联合治疗。
J Immunother Cancer. 2018 Jun 4;6(1):47. doi: 10.1186/s40425-018-0356-4.
2
Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression.代谢应激下通过 CaMK2α 介导的肌浆/内质网钙 ATP 酶表达上调促进肿瘤干细胞样细胞存活。
Clin Cancer Res. 2018 Apr 1;24(7):1677-1690. doi: 10.1158/1078-0432.CCR-17-2219. Epub 2017 Dec 26.
3
前哨淋巴结与非前哨淋巴结中树突状细胞和巨噬细胞分布的差异:一项使用早期胃癌前哨淋巴结导航手术获取的胃区域淋巴结进行的免疫组织化学和形态计量学研究。
J Anat. 2025 Feb;246(2):272-287. doi: 10.1111/joa.14147. Epub 2024 Oct 5.
4
The role of vascular and lymphatic networks in bone and joint homeostasis and pathology.血管和淋巴管网络在骨骼和关节稳态和病理学中的作用。
Front Endocrinol (Lausanne). 2024 Sep 11;15:1465816. doi: 10.3389/fendo.2024.1465816. eCollection 2024.
5
The paradoxical role of transforming growth factor-β in controlling oral squamous cell carcinoma development.转化生长因子-β在控制口腔鳞状细胞癌发展中的矛盾作用。
Cancer Biomark. 2024;40(3-4):241-250. doi: 10.3233/CBM-230354.
6
SLC2A3 promotes tumor progression through lactic acid-promoted TGF-β signaling pathway in oral squamous cell carcinoma.SLC2A3 通过乳酸促进的 TGF-β 信号通路促进口腔鳞状细胞癌的肿瘤进展。
PLoS One. 2024 Apr 16;19(4):e0301724. doi: 10.1371/journal.pone.0301724. eCollection 2024.
7
Prediction of immune infiltration and prognosis for patients with gastric cancer based on the immune-related genes signature.基于免疫相关基因特征对胃癌患者免疫浸润及预后的预测
Heliyon. 2023 Nov 23;9(12):e22433. doi: 10.1016/j.heliyon.2023.e22433. eCollection 2023 Dec.
8
Lymphatic vessel: origin, heterogeneity, biological functions, and therapeutic targets.淋巴管:起源、异质性、生物学功能和治疗靶点。
Signal Transduct Target Ther. 2024 Jan 3;9(1):9. doi: 10.1038/s41392-023-01723-x.
9
Lymphangiogenesis in gastric cancer: function and mechanism.胃癌中的淋巴管生成:功能与机制。
Eur J Med Res. 2023 Oct 7;28(1):405. doi: 10.1186/s40001-023-01298-x.
10
Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.癌症进展中的淋巴结转移:分子机制、临床意义和治疗干预。
Signal Transduct Target Ther. 2023 Sep 27;8(1):367. doi: 10.1038/s41392-023-01576-4.
Stromal gene expression defines poor-prognosis subtypes in colorectal cancer.基质基因表达定义了结直肠癌的预后不良亚型。
Nat Genet. 2015 Apr;47(4):320-9. doi: 10.1038/ng.3225. Epub 2015 Feb 23.
4
Differential regulation of TGF-β-induced, ALK-5-mediated VEGF release by SMAD2/3 versus SMAD1/5/8 signaling in glioblastoma.胶质母细胞瘤中SMAD2/3与SMAD1/5/8信号通路对转化生长因子-β诱导的、ALK-5介导的血管内皮生长因子释放的差异调节
Neuro Oncol. 2015 Feb;17(2):254-65. doi: 10.1093/neuonc/nou218. Epub 2014 Aug 27.
5
SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.SIX1 通过协调 TGFβ 信号增加 VEGF-C 的表达促进肿瘤淋巴管生成。
Cancer Res. 2014 Oct 1;74(19):5597-607. doi: 10.1158/0008-5472.CAN-13-3598. Epub 2014 Aug 20.
6
Comprehensive molecular characterization of gastric adenocarcinoma.胃腺癌的全面分子特征分析。
Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.
7
Transforming growth factor-β as a therapeutic target in hepatocellular carcinoma.转化生长因子-β作为肝细胞癌的治疗靶点。
Cancer Res. 2014 Apr 1;74(7):1890-4. doi: 10.1158/0008-5472.CAN-14-0243. Epub 2014 Mar 17.
8
Lymphangiogenic and angiogenic microvessel density in chinese patients with gastric carcinoma: correlation with clinicopathologic parameters and prognosis.中国胃癌患者淋巴管生成和血管生成微血管密度:与临床病理参数及预后的相关性
Asian Pac J Cancer Prev. 2013;14(8):4549-52. doi: 10.7314/apjcp.2013.14.8.4549.
9
Comprehensive genomic meta-analysis identifies intra-tumoural stroma as a predictor of survival in patients with gastric cancer.全面的基因组荟萃分析确定肿瘤内基质是预测胃癌患者生存的一个指标。
Gut. 2013 Aug;62(8):1100-11. doi: 10.1136/gutjnl-2011-301373. Epub 2012 Jun 26.
10
Transforming growth factor-β induces vascular endothelial growth factor-C expression leading to lymphangiogenesis in rat unilateral ureteral obstruction.转化生长因子-β诱导血管内皮生长因子-C 表达导致大鼠单侧输尿管梗阻中的淋巴管生成。
Kidney Int. 2012 May;81(9):865-79. doi: 10.1038/ki.2011.464. Epub 2012 Jan 18.